Amgen disclosed a significant cybersecurity breach on July 31, 2026. Hackers gained unauthorized access to data stored in third-party cloud environments. The stolen files include proprietary company data and protected patient health information.
The drugmaker activated a response plan to implement containment measures. Independent forensic experts are currently investigating the incident.
Amgen confirmed the breach has not affected manufacturing operations, products, or financial systems. The company does not expect the event to have a material impact on its financial condition or results of operations.